# Strand Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/strand-therapeutics

- Industry: Biotechnology
- Headquarters: Boston, US
- Website: www.strandtx.com
- Total disclosed funding: $256M
- Latest round: Series B (Aug 3, 2025)
- Investors on record: 17

## About

Founded in 2017 and headquartered in Massachusetts, US, Strand Therapeutics Inc. specializes in developing programmable, long-acting mRNA therapeutics, focusing on innovative treatments for cancer and other serious diseases through advanced biotechnology. focuses on creating mRNA-based medicines. In August 2025, Strand Therapeutics Inc. raised USD 153 million in series B funding led by new investor Kinnevik, with participation from other new investors ICONIQ Capital, Regeneron Ventures, JIC Venture Growth Investments, Alderline Group, LG Technology Ventures, Gradiant Corporation, and Amgen Inc. Returning investors Playground Ventures, FPV Ventures, Eli Lilly & Company, ANRI, Potentum, and other unspecified investors also participated in the round.

## Funding rounds

- Series B, Aug 3, 2025, $153M — Kinnevik, Amgen Inc., Eli Lilly & Company, ICONIQ Capital, ANRI, Playground Ventures, LG Technology Ventures, JIC Venture Growth Investments, Potentum Partners, FPV Ventures, Regeneron Ventures, Alderline Group
- Series A, Nov 28, 2022, $45M — Eli Lilly & Company, Playground Ventures, Potentum Partners, FPV Ventures
- Series A, Jun 23, 2021, $52M — Redmile Group, ANRI, BeiGene Ltd., Playground Ventures, Camford
- Seed, Jun 4, 2019, $6M — Alexandria Venture Investments, ANRI, Playground Global, LLC

## Investors

- Alexandria Venture Investments (https://capitalatlas.ai/funds/alexandria-venture-investments) — Seed
- ANRI (https://capitalatlas.ai/funds/anri) — Seed, Series A, Series B
- Playground Global, LLC — Seed
- Redmile Group (https://capitalatlas.ai/funds/redmile-group) — Series A
- BeiGene Ltd. — Series A
- Playground Ventures (https://capitalatlas.ai/funds/playground-ventures) — Series A, Series B
- Camford (https://capitalatlas.ai/funds/camford) — Series A
- Eli Lilly & Company — Series A, Series B
- Potentum Partners (https://capitalatlas.ai/funds/potentum-partners) — Series A, Series B
- FPV Ventures (https://capitalatlas.ai/funds/fpv-ventures) — Series A, Series B
- Kinnevik (https://capitalatlas.ai/funds/kinnevik) — Series B
- Amgen Inc. — Series B
- ICONIQ Capital (https://capitalatlas.ai/funds/iconiq-capital) — Series B
- LG Technology Ventures (https://capitalatlas.ai/funds/lg-technology-ventures) — Series B
- JIC Venture Growth Investments (https://capitalatlas.ai/funds/jic-venture-growth-investments) — Series B
- Regeneron Ventures (https://capitalatlas.ai/funds/regeneron-ventures) — Series B
- Alderline Group (https://capitalatlas.ai/funds/alderline-group) — Series B